Patents by Inventor Richard H. P. Porter

Richard H. P. Porter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Thiazolo[4,5-C]pyridine derivatives
    Patent number: 7659401
    Abstract: The invention relates to compounds of general formula I: wherein R1, R2 and R3 are as defined in the description such compounds are metabotropic glutamate receptor antagonists and are useful in the treatment or prevention of mGluR5 receptor mediated disorders.
    Type: Grant
    Filed: October 31, 2006
    Date of Patent: February 9, 2010
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Georg Jaeschke, Sabine Kolczewski, Richard H. P. Porter, Patrick Schnider, Eric Vieira
  • (?)-mefloquine to block puringergic receptors and to treat movement or neurodegenerative disorders
    Patent number: 6197788
    Abstract: The present invention relates to the use of (±)-R*,S*)-alpha-2-piperidnyl-2,8-bis(trifluoromethyl)-4-quinolinemthanol and in particular (−)-(11S,2′R)-alpha-2-piperidnyl-2,8-bis(trifluoromethyl)-4-quinolinemthanol in the treatment of disorders in which the reduction of purinergic neurotransmission could be beneficial. The invention relates in particular to adenosine receptors, and particularly adenosine A2a receptors and to the treatment of movement disorders such as Parkinson's disease.
    Type: Grant
    Filed: September 27, 1999
    Date of Patent: March 6, 2001
    Assignee: Vernalis Research Limited
    Inventors: Allan Fletcher, Lars Jacob Stray Knutsen, Richard H. P. Porter, Scott Murray Weiss, Robin Shepherd